| Mohammed Hussein Nasser Aljarwi, MD | |
|
4214 Andrews Hwy Ste 102, Midland, TX 79703-4815 | |
| (432) 221-5580 | |
| (432) 221-5585 |
| Full Name | Mohammed Hussein Nasser Aljarwi |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 4214 Andrews Hwy Ste 102, Midland, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013320050 | NPI | - | NPPES |
| Q9276 | Other | TX | TEXAS MEDICAL BOARD LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | Q9276 (Texas) | Primary |
| Entity Name | Premier Family Care I, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275522864 PECOS PAC ID: 2567351372 Enrollment ID: O20040311000343 |
News Archive
New research from social psychologists at Indiana University Bloomington suggests that feeling powerful might protect against the debilitating effects of negative stereotypes.
A new genetic discovery in the field of Huntington's disease (HD) could mean a more effective way in determining severity of this neurological disease when using specific treatments. This study may provide insight for treatments that would be effective in slowing down or postponing the death of neurons for people who carry the HD gene mutation, but who do not yet show symptoms of the disease.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure.
FDA Device Division, still concerned about mercury toxicity in American dentistry, is convening yet another professional panel review regarding safety issues. A nationwide convergence of scientists, dental and medical professionals, lead by the International Academy of Oral Medicine and Toxicology (IAOMT) are provoking new challenges to the Food and Drug Administration's (FDA) July'09 "no risk" classification of mercury fillings .
OrbusNeich's Genous Bio-engineered R stent is feasible and safe in patients who need coronary revascularization before undeferrable non-cardiac surgery and have to discontinue dual antiplatelet therapy, according to a paper published online in the International Journal of Cardiology (Int J Cardiol. 2009 Aug 21. [Epub ahead of print]).
› Verified 4 days ago
| Entity Name | Covenant Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598904 PECOS PAC ID: 6901889393 Enrollment ID: O20040608000563 |
News Archive
New research from social psychologists at Indiana University Bloomington suggests that feeling powerful might protect against the debilitating effects of negative stereotypes.
A new genetic discovery in the field of Huntington's disease (HD) could mean a more effective way in determining severity of this neurological disease when using specific treatments. This study may provide insight for treatments that would be effective in slowing down or postponing the death of neurons for people who carry the HD gene mutation, but who do not yet show symptoms of the disease.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure.
FDA Device Division, still concerned about mercury toxicity in American dentistry, is convening yet another professional panel review regarding safety issues. A nationwide convergence of scientists, dental and medical professionals, lead by the International Academy of Oral Medicine and Toxicology (IAOMT) are provoking new challenges to the Food and Drug Administration's (FDA) July'09 "no risk" classification of mercury fillings .
OrbusNeich's Genous Bio-engineered R stent is feasible and safe in patients who need coronary revascularization before undeferrable non-cardiac surgery and have to discontinue dual antiplatelet therapy, according to a paper published online in the International Journal of Cardiology (Int J Cardiol. 2009 Aug 21. [Epub ahead of print]).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammed Hussein Nasser Aljarwi, MD Po Box 5291, Midland, TX 79704-5291 Ph: (432) 221-5970 | Mohammed Hussein Nasser Aljarwi, MD 4214 Andrews Hwy Ste 102, Midland, TX 79703-4815 Ph: (432) 221-5580 |
News Archive
New research from social psychologists at Indiana University Bloomington suggests that feeling powerful might protect against the debilitating effects of negative stereotypes.
A new genetic discovery in the field of Huntington's disease (HD) could mean a more effective way in determining severity of this neurological disease when using specific treatments. This study may provide insight for treatments that would be effective in slowing down or postponing the death of neurons for people who carry the HD gene mutation, but who do not yet show symptoms of the disease.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure.
FDA Device Division, still concerned about mercury toxicity in American dentistry, is convening yet another professional panel review regarding safety issues. A nationwide convergence of scientists, dental and medical professionals, lead by the International Academy of Oral Medicine and Toxicology (IAOMT) are provoking new challenges to the Food and Drug Administration's (FDA) July'09 "no risk" classification of mercury fillings .
OrbusNeich's Genous Bio-engineered R stent is feasible and safe in patients who need coronary revascularization before undeferrable non-cardiac surgery and have to discontinue dual antiplatelet therapy, according to a paper published online in the International Journal of Cardiology (Int J Cardiol. 2009 Aug 21. [Epub ahead of print]).
› Verified 4 days ago
Dr. Wellington F Ballesteros, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 Delano Ave, Midland, TX 79701 Phone: 432-697-4747 Fax: 432-699-3813 | |
Nidhi Girishchandra Shah, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4214 Andrews Hwy Ste 310, Midland, TX 79703 Phone: 432-697-4747 Fax: 432-699-3813 | |
Chandan Mazumder, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1900 W Wall St Ste C, Midland, TX 79701 Phone: 432-221-2500 Fax: 432-687-1914 | |
Jennifer Blackerby, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3600 N Garfield St, Midland, TX 79705 Phone: 432-620-1120 | |
Kranthi Nandan Seelaboyina, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 316 Secor St, Midland, TX 79701 Phone: 432-620-1111 Fax: 432-620-1112 | |
Megan Breanne Rossman, PA-C Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 302 Secor St, Midland, TX 79701 Phone: 432-685-5029 |